ArthNow Logo
ArthNow
•2 min read•
✦Reported by Free Press Journal

HRS Aluglaze H1 FY27 Results Show ₹33.7 Crore Revenue And ₹115 Crore Order Book, But A Sharp Profit Fall Raises Questions

HRS Aluglaze H1 FY27 Results Show ₹33.7 Crore Revenue And ₹115 Crore Order Book, But A Sharp Profit Fall Raises Questions
Source: Free Press Journal

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓HRS Aluglaze reported a 27.8% revenue rise to ₹33.7 crore for the first half of FY27.
  • ✓Despite this growth, consolidated net profit fell to ₹0.9 crore from ₹4.5 crore.
  • ✓The company maintained a ₹115.44 crore order book on September 30, 2026, while investing ₹25.7 crore in new fixed assets.

Story at a Glance

Category
Indian Markets
Reported By
Free Press Journal
Reading Speed
2 Minute(s)
Market Focus
India Economy

Mumbai: HRS Aluglaze Limited reported a 27.8% year-on-year increase in consolidated revenue to ₹33.7 crore for the first half of FY27, compared with ₹26.3 crore in the corresponding period last year. However, the company's consolidated net profit declined sharply despite improved revenue performance.

HRS Aluglaze H1 FY27 Financial Results

According to the company's announcement on November 19, 2026, standalone revenue rose 19.8% to ₹31.6 crore during the six months ended September 30, 2026, against ₹26.3 crore in H1 FY26.

Standalone profit after tax (PAT) stood at ₹1.9 crore. However, consolidated net profit fell to ₹0.9 crore from ₹4.5 crore in the year-ago period, highlighting pressure on overall profitability. The contrasting revenue and profit trends remained a key feature of HRS Aluglaze's half-year financial performance.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Free Press Journal

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.